Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Science ; 324(5925): 381-4, 2009 Apr 17.
Artigo em Inglês | MEDLINE | ID: mdl-19372430

RESUMO

Oxygen deprivation is rapidly deleterious for most organisms. However, Caenorhabditis elegans has developed the ability to survive anoxia for at least 48 hours. Mutations in the DAF-2/DAF-16 insulin-like signaling pathway promote such survival. We describe a pathway involving the HYL-2 ceramide synthase that acts independently of DAF-2. Loss of the ceramide synthase gene hyl-2 results in increased sensitivity of C. elegans to anoxia. C. elegans has two ceramide synthases, hyl-1 and hyl-2, that participate in ceramide biogenesis and affect its ability to survive anoxic conditions. In contrast to hyl-2(lf) mutants, hyl-1(lf) mutants are more resistant to anoxia than normal animals. HYL-1 and HYL-2 have complementary specificities for fatty acyl chains. These data indicate that specific ceramides produced by HYL-2 confer resistance to anoxia.


Assuntos
Proteínas de Caenorhabditis elegans/genética , Proteínas de Caenorhabditis elegans/metabolismo , Caenorhabditis elegans/fisiologia , Hipóxia Celular , Ceramidas/fisiologia , Oxirredutases/genética , Oxirredutases/metabolismo , Oxigênio/fisiologia , Animais , Apoptose , Caenorhabditis elegans/citologia , Caenorhabditis elegans/genética , Ceramidas/biossíntese , Deleção de Genes , Genes de Helmintos , Mutação , Receptor de Insulina/genética , Receptor de Insulina/metabolismo , Saccharomyces cerevisiae/genética , Saccharomyces cerevisiae/crescimento & desenvolvimento , Saccharomyces cerevisiae/fisiologia , Esfingomielinas/biossíntese , Esfingomielinas/fisiologia , Especificidade por Substrato , Transformação Genética , Transgenes
2.
J Biol Chem ; 277(36): 32632-9, 2002 Sep 06.
Artigo em Inglês | MEDLINE | ID: mdl-12082098

RESUMO

The apoptotic protein tBid is effective in promoting both leakage and lipid mixing in liposomes composed of cardiolipin and phosphatidylcholine at a molar ratio of 1:2 in the presence of calcium. When half of the phosphatidylcholine component of these liposomes is replaced with phosphatidylethanolamine, a lipid that promotes negative membrane curvature, the rates of both leakage and lipid mixing caused by tBid are substantially increased. Replacement of cardiolipin with phosphatidylglycerol, a lipid that is structurally similar to cardiolipin but does not promote negative membrane curvature in the presence of calcium, prevents the tBid from promoting leakage. The promotion of leakage by tBid is also inhibited by several substances that promote positive membrane curvature, including lysophosphatidylcholine, tritrpticin, a potent antimicrobial peptide, and cyclosporin A, a known inhibitor of cytochrome c release from mitochondria. We directly measured the effect of tBid on membrane curvature by (31)P NMR. We found that tBid promotes the formation of highly curved non-lamellar phases. All of these data are consistent with the hypothesis that tBid promotes negative curvature, and as a result it destabilizes bilayer membranes. Bcl-X(L) inhibits leakage and lipid mixing induced by tBid. Bcl-X(L) is anti-apoptotic. It reduces the promotion of non-bilayer phases by tBid, although by itself Bcl-X(L) is capable of promoting their formation. Bcl-X(L) has little effect on liposomal integrity. Our results suggest that the anti-apoptotic activity of Bcl-X(L) is not a consequence of its interaction with membranes, but rather with other proteins, such as tBid.


Assuntos
Apoptose , Proteínas de Transporte/química , Proteínas de Transporte/fisiologia , Membrana Celular/metabolismo , Fragmentos de Peptídeos/química , Fragmentos de Peptídeos/fisiologia , Proteína Agonista de Morte Celular de Domínio Interatuante com BH3 , Cloreto de Cálcio/farmacologia , Cardiolipinas/metabolismo , Proteínas de Transporte/metabolismo , Membrana Celular/efeitos dos fármacos , Ciclosporina/farmacologia , Grupo dos Citocromos c/metabolismo , Inibidores Enzimáticos/farmacologia , Células HeLa , Humanos , Bicamadas Lipídicas/metabolismo , Metabolismo dos Lipídeos , Lipossomos/metabolismo , Espectroscopia de Ressonância Magnética , Mitocôndrias/metabolismo , Oligopeptídeos/farmacologia , Fragmentos de Peptídeos/metabolismo , Fosfatidiletanolaminas/farmacologia , Fosfolipídeos/metabolismo , Ligação Proteica , Proteínas Proto-Oncogênicas c-bcl-2/metabolismo , Temperatura , Fatores de Tempo , Proteína bcl-X
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...